Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is associated with hyperinsulinemia, insulin resistance (IR), increased risk of glucose intolerance, and type 2 diabetes. Family studies have indicated a genetic susceptibility to PCOS. The aims of this study were 1) to assess glucose tolerance status, gonadotropins, and androgens in first degree relatives of patients with PCOS; and 2) to assess IR in normal glucose tolerant (NGT) family members. One hundred two family members of 52 patients with PCOS [MothersPCOS (n = 34; mean age, 46.5 yr; mean body mass index (BMI), 28.8 kg/m2), FathersPCOS (n = 24; mean age, 50.4 yr; mean BMI, 27.5 kg/m2), SistersPCOS (n = 19; mean age, 25.1 yr; mean BMI, 22.9 kg/m2), and BrothersPCOS (n = 25; mean age, 23.7 yr; mean BMI, 22.5 kg/m2)] and 82 unrelated healthy control subjects without a family history of diabetes or PCOS (4 age- and weight-matched subgroups, i.e. ControlMothersPCOS, ControlFathersPCOS, ControlSistersPCOS, and ControlBrothersPCOS) were studied. Glucose and insulin (at baseline and during a 75-g, 2-h oral glucose tolerance test) were measured. IR was assessed by fasting insulin (FI), fasting glucose to insulin ratio (FGI), homeostatic model assessment (HOMA IR), and area under the curve for insulin during the oral glucose tolerance test (AUCinsulin) in NGT MothersPCOS, FathersPCOS, SistersPCOS, BrothersPCOS, and matched control subgroups. Including the prestudy-diagnosed 3 mothers and 2 fathers with diabetes, diabetes and impaired glucose tolerance (IGT) were noted in 16% and 30% of MothersPCOS and 27% and 31% of FathersPCOS, respectively. There was no diabetes in SistersPCOS and BrothersPCOS. IGT was found in 5% of SistersPCOS. Impaired fasting glucose was found in 3% of MothersPCOS and 4% of BrothersPCOS. The analysis of NGT family members showed that MothersPCOS had higher FI (P < 0.05), HOMA IR (P < 0.05), and AUCinsulin (P < 0.01) and lower FGI (P < 0.05) than ControlMothersPCOS, whereas all IR parameters were comparable between FathersPCOS and their matched control subgroup. SistersPCOS had higher FI (P < 0.05), HOMA IR (P < 0.01), and AUCinsulin (P < 0.05) and lower FGI (P < 0.01), and BrothersPCOS had higher AUCinsulin (P < 0.01) than their matched control subgroups, respectively. MothersPCOS had higher testosterone levels than ControlMothersPCOS (P < 0.01 and P < 0.05 for pre- and postmenopausal women, respectively). SistersPCOS had higher LH (P < 0.01), testosterone (P < 0.001), androstenedione (P < 0.01), and dehydroepiandrosterone sulfate (P < 0.05) levels than ControlSistersPCOS. There was no difference in gonadotropin and androgen levels in FathersPCOS compared with ControlFathersPCOS or in BrothersPCOS compared with ControlBrothersPCOS. Our results suggest that 1) first degree relatives of patients with PCOS may be at high risk for diabetes and glucose intolerance; 2) NGT female family members have insulin resistance; and 3) mothers and sisters of PCOS patients have higher androgen levels than control subjects. We propose that the high risks of these impairments warrant screening in first degree relatives of patients with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“Abnormalities of carbohydrate metabolism such as insulin resistance, impaired glucose tolerance, type 2 DM tend to cluster in families with PCOS (33, 34).”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
Legro, R. S., Castracane, V. D., & Kauffman, R. P. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000109523.25076.e2 · Cited by 453
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque-Ramírez, M., & San Millán, J. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 422
Orio, F., Palomba, S., Cascella, T., De Simone, B., Di Biase, S., Russo, T., Labella, D., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031867 · Cited by 330
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K., Nestler, J. E., Sattar, N., & Lehnert, H. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1003 · Cited by 322
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Polycystic ovary syndrome and its developmental origins
Dumesic, D. A., Abbott, D. H., & Padmanabhan, V. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9046-0 · Cited by 283
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
The role of genes and environment in the etiology of PCOS
Diamanti-Kandarakis, E., Kandarakis, H., & Legro, R. S. (2006) · Endocrine · doi:10.1385/endo:30:1:19 · Cited by 233
Abbott, D. H., Tarantal, A. F., & Dumesic, D. A. (2009) · American Journal of Primatology · doi:10.1002/ajp.20679 · Cited by 177
“J. Primatol. all been found in fathers and/or brothers of women with PCOS [Fox, 1999; Sam et al., 2008a,b; Sir-Petermann et al., 2002; Yildiz et al., 2003].”
BackgroundPolycystic ovary syndrome: An ancient disorder?
Azziz, R., Dumesic, D. A., & Goodarzi, M. O. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.09.032 · Cited by 164
Pall, M., Azziz, R., Beires, J., & Pignatelli, D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.025 · Cited by 123
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
Leibel, N. I., Baumann, E. E., Kocherginsky, M., & Rosenfield, R. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1707 · Cited by 118
de Melo, A. S., Dias, S. V., Cavalli, R. D. C., Cardoso, V. C., Bettiol, H., Barbieri, M. A., Ferriani, R. A., & Vieira, C. S. (2015) · Reproduction · doi:10.1530/rep-14-0499 · Cited by 99
“Studies of first-degree relatives of women with PCOS demonstrated an increased incidence of abnormal glucose metabolism and metabolic syndrome in men, which suggests a genetic background effect (Yildiz et al. 2003).”
Perspectives in polycystic ovary syndrome: From hair to eternity
Dunaif, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3780 · Cited by 87
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
Abbott, D. H., & Bacha, F. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.023 · Cited by 67
Hyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., & Spritzer, P. M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.009 · Cited by 47
“A genetic basis has been proposed for PCOS because the prevalence of this disease is higher among family members [12,13].”
BackgroundPolycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
Kousta, E., Tolis, G., & Franks, S. (2005) · HORMONES · doi:10.14310/horm.2002.11151 · Cited by 35
Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome
Kalra, P., Bansal, B., Nag, P., Singh, J. K., Gupta, R. K., Kumar, S., Rathore, R. K. S., Bhatia, V., & Bhatia, E. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.037 · Cited by 37
Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
Cheang, K. I., Nestler, J. E., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1084 · Cited by 31
Developmental androgen excess disrupts reproduction and energy homeostasis in adult male mice
Nohara, K., Liu, S., Meyers, M. S., Waget, A., Ferron, M., Karsenty, G., Burcelin, R., & Mauvais-Jarvis, F. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0230 · Cited by 28
Fetal androgen excess provides a developmental origin for polycystic ovary syndrome
Abbott, D. H., & Dumesic, D. A. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.4.1.1 · Cited by 11
Role of hyperinsulinemic insulin resistance in polycystic ovary syndrome
Iuorno, M. J. (2001) · Polycystic Ovary Syndrome · doi:10.1017/cbo9780511545191.013 · Cited by 3
Metadata
- Authors
- Yildiz, B. O., Yarali, H., Oguz, H., & Bayraktar, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-05-01
- Volume
- 88
- Issue
- 5
- Pages
- 2031-2036
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2148120261
- Cited by
- 275
- References
- 39
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.